Exploring the current landscape of screening services in women’s cancers and market opportunities to address unmet need.
Sharing how AI, technology, and genetic testing can address gaps in access.
How providers and patients can be equipped with tools for early detection and cancer prevention.
Session Topics:
Oncology
Speaker(s):
Heidi Glasser
Director of Corporate Affairs
Medicines360
Kristine Cecchetti
Senior Product Manager, Women’s Health Strategy
Evernorth
Mary Dinnean
Director, Enterprise Strategic Initiatives
Elevance Health
Rachel Brem
Chief Medical Director
Brem Foundation
Session Job Focus:
Time:
2:00 PM - 2:30 PM
Agenda Track No.:
Track 8
Session Type:
Track